These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7536475)

  • 1. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
    Thiele J; Kvasnicka HM; Niederle N; Zirbes TK; Schmidt M; Dammasch J; Meuter BR; Leder LD; Kloke O; Diehl V
    Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
    Thiele J; Zirbes T; Kvasnicka HM; Niederle N; Dammasch J; Schmidt M; Windecker R; Leder LD; Diehl V; Fischer R
    Anal Cell Pathol; 1996 Jun; 11(1):31-42. PubMed ID: 8844103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histo- and immunomorphometry of megakaryopoiesis in chronic myeloid leukemia with myelofibrosis and so-called primary (idiopathic) osteo-myelofibrosis/-sclerosis.
    Thiele J; Steinberg T; Hoeppner B; Wienhold S; Wagner S; Dienemann D; Fischer R
    Anal Cell Pathol; 1990 Jul; 2(4):215-27. PubMed ID: 2275869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy.
    Thiele J; Zirbes TK; Lorenzen J; Kvasnicka HM; Dresbach S; Manich B; Leder LD; Niederle N; Diehl V; Fischer R
    J Pathol; 1997 Mar; 181(3):316-22. PubMed ID: 9155719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Leder LD; Schaefer HE
    Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Spohr M; Diehl V; Zankovich R; Niederle N; Leder LD
    Br J Haematol; 2000 Jan; 108(1):64-71. PubMed ID: 10651725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zirbes TK; Birnbaum F; Kressmann C; Melguizo-Grahmann M; Frackenpohl H; Sprungmann C; Leder LD; Diehl V; Zankovich R; Schaefer HE; Niederle N; Fischer R
    Leuk Lymphoma; 2000 Jan; 36(3-4):295-308. PubMed ID: 10674901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interferon therapy on bone marrow morphology in chronic myeloid leukemia: a cytochemical and immunohistochemical study of trephine biopsies.
    Thiele J; Zirbes TK; Kvasnicka HM; Lorenzen J; Niederle N; Leder LD; Fischer R
    J Interferon Cytokine Res; 1996 Mar; 16(3):217-24. PubMed ID: 8697144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histologic and hematological findings in CML. A comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)].
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Schaefer HE
    Pathologe; 2000 Jan; 21(1):39-54. PubMed ID: 10663668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot study.
    Thiele J; Kvasnicka HM; Niederle N; Kloke O; Schmidt M; Lienhard H; Zirbes T; Meuter RB; Leder LD; Fischer R
    Am J Hematol; 1995 Sep; 50(1):30-9. PubMed ID: 7545352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation.
    Thiele J; Kvasnicka HM; Beelen DW; Pilgram B; Rose A; Leder LD; Schaefer UW
    Leukemia; 2000 Aug; 14(8):1378-85. PubMed ID: 10942232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.
    Ohsaka A; Miura Y; Takahashi A; Yokoyama T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(6):399-405. PubMed ID: 1683056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of interferon treatment on the macrophage population in the bone marrow of patients with Ph1+-CML.
    Thiele J; Kvasnicka HM; Zirbes TK; Baldus SE; Djuren O; Lienhard H; Lorenzen J; Leder LD; Niederle N; Fischer R
    Hematopathol Mol Hematol; 1996; 10(4):201-12. PubMed ID: 9042663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
    Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia.
    Wilhelm M; Bueso-Ramos C; O'Brien S; Pierce S; Keating M; Talpaz M; Kantarjian HM
    Leukemia; 1998 Jan; 12(1):65-70. PubMed ID: 9436922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Zirbes TK; Jung F; Reske D; Leder LD; Schaefer UW
    Bone Marrow Transplant; 2000 Aug; 26(3):275-81. PubMed ID: 10967565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
    Straetmans N; Ma DD; Nevell DF; Arthur C
    Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients.
    Thiele J; Kvasnicka HM; Beelen DW; Leder LD; Schaefer UW
    Histol Histopathol; 2001 Jan; 16(1):213-26. PubMed ID: 11193198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.